Skip to content
value.today

Evergreen Theragnostics Inc.

🇺🇸 Chatham, New Jersey, USAPharmaceuticalsFounded 2019
Total raised
$35 M
2 rounds on record
Latest round
$15 M
Dec 2022
First round on record
Apr 2020
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Evergreen Theragnostics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2022$15 MNo. 2$10 to $50 million

Evergreen Theragnostics Inc.: Raise no. 2, Dec 2022

Investors in this round

58 investors had bought by the notice of Aug 18, 2023: 58 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Cook · Executive Officer, Director
  • Enrico De Maria · Director
  • Gerard Ber · Director
  • Serge Lyashchenko · Director
  • Sharon Roded · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those set forth in Item 3.”

Signed by James Cook, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 18, 2023. Read the notice at the SEC.

equitySEC
Apr 2020$19 MNo. 1$10 to $50 million

Evergreen Theragnostics Inc.: Raise no. 1, Apr 2020

Investors in this round

76 investors had bought by the notice of Jun 30, 2020: 76 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $25 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Cook · Executive Officer, Director
  • Enrico De Maria · Director
  • Gerard Ber · Director
  • Serge Lyashchenko · Director
  • Victor Paulus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those set forth in Item 3.”

Signed by James Cook, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 30, 2020. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Evergreen Theragnostics Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2023).

    SEC Form D · Aug 2023

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Aug 2023

That is all the official record says: Evergreen Theragnostics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Evergreen Theragnostics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 76 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Evergreen Theragnostics Inc.
NameRoleNamed in
James CookExecutive officerAug 2023
Enrico De MariaDirectorAug 2023
Gerard BerDirectorAug 2023
James CookDirectorAug 2023
Serge LyashchenkoDirectorAug 2023
Sharon RodedDirectorAug 2023
Victor PaulusDirectorJun 2020